Table 3.
Stage 2: association of selected loci with PGD*
| Locus | Risk/Ref alleles | RAF no PGD | RAF PGD | OR (95%CI) | P value | Gene | Location |
|---|---|---|---|---|---|---|---|
| rs3168046 | A/G | 0.44 | 0.51 | 1.42 (1.11; 1.83) | 0.0061 | TOLLIP | 3′UTR |
| rs30008 | T/C | 0.24 | 0.22 | 1.21 (0.912; 1.61) | 0.1845 | CD37 | intron |
| rs4149338 | T/C | 0.30 | 0.33 | 1.15 (0.88; 1.51) | 0.3178 | ABCA1 | 3′UTR |
| rs832573 | T/C | 0.34 | 0.29 | 1.13 (0.87; 1.45) | 0.3583 | MAP3K1 | Intron |
| rs866223 | A/G | 0.43 | 0.38 | 1.09 (0.85; 1.40) | 0.4870 | MAP3K1 | Intron |
| rs10195871 | T/C | 0.33 | 0.33 | 0.96 (0.74; 1.24) | 0.7350 | BCL11A | intron |
Abbreviations: RAF risk allele frequency; OR, odds ratio; CI, confidence interval; 3′UTR, 3′ untranslated region. Note: A Bonferroni-adjusted P < 0.008 was considered significant to account for the six loci tested.
Adjusted for cardiopulmonary bypass, diagnosis, and population admixture.